retatrutide approval just took a major step toward FDA approval, and the numbers are unlike anything we've seen from a weight-loss injection. In Eli Lilly's phase 3 TRIUMPH-1 trial, participants on the highest retatrutide approval 🎥 Eli Lilly's

Copper is essential for angiogenesis, nerve growth, and antioxidant defense

Athletes face even higher rates, with soccer players experiencing hip and groin issues in up to 55 percent of men and 45 percent of women according to sports medicine research

Real-world data on effectiveness and safety may differ from findings in controlled studies, highlighting the need for additional larger-scale studies and real-world data to guide clinical decision-making

What to consider before starting a GLP-1 in perimenopause These are a few key factors to consider when deciding if GLP-1 is the right choice to manage your perimenopause weight gain: Body weight: The FDA approves GLP-1 medications primarily for individuals with a body mass index (BMI) of 30 or above, or a BMI of 27 or above alongside a weight-related health condition like high blood pressure or prediabetes

doi: 10.1056/NEJM199503093321001 32 RosenbaumMHirschJGallagherDALeibelRL

Aside from that, it offers a lot more